News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Andrea Apolo: Phase 1 study of Cabozantinib, Nivolumab, and Ipilimumab for genitourinary tumours
Photo from Andrea Apolo/X
Jul 5, 2024, 15:03

Andrea Apolo: Phase 1 study of Cabozantinib, Nivolumab, and Ipilimumab for genitourinary tumours

Andrea Apolo, Chief of Bladder Cancer Section Genitourinary Malignancies Branch Center for Cancer Research at NCI, shared on X:

“Cabozantinib/Nivolumab and Cabozantinib/Nivolumab/Ipilimumab have shown promising efficacy and safety in patients with metastatic urothelial carcinoma, metastatic renal cell carcinoma and rare GU tumors in a dose-escalation phase I study.”

Andrea Apolo

Additional information.
Source: Andrea Apolo/X

Andrea Apolo Cabozantinib cancer ipilimumab metastatic renal cell carcinoma nivolumab OncoDaily Oncology urothelial carcinoma
Special Coverage
Opinion
Apr 16, 2025, 19:46
President of the Oncology Nursing Society opened the 50th Annual ONS Congress - Sylvester Comprehensive Cancer Center
Blog
Apr 16, 2025, 19:26
Laura Moliner: Don’t miss this must-see webinar on Liquid Biopsy in Lung Cancer
Blog
Apr 16, 2025, 19:01
Richard Sullivan: WHO Meeting Reflected on Cancer and IO Drug Pairs
Blog
Apr 16, 2025, 18:50
Join the Third Annual Virtual TAPUR Study Grand Rounds 2025 - ASCO
Blog
Apr 16, 2025, 18:44
The month of the Explore Your Health festival is coming to an end - IARC/WHO
Blog
Apr 16, 2025, 18:38
Why doesn't your body attack the food you eat? - Cancer Research Institute
Blog
Apr 16, 2025, 18:33
Massive Bio has officially received certification from the CNIL
Blog
Apr 16, 2025, 18:17
Peter Pisters: It was wonderful to drop by MD Anderson Cancer Center’s LEADing Leaders/LEADing Institution Training
Blog
Apr 16, 2025, 18:15
MASCC Guidance on Osteoradionecrosis in Patients with Head and Neck Cancer
Blog
Apr 16, 2025, 17:56
Study MSc Transformative Oncology from The University of Manchester online and part-time
Blog
Apr 16, 2025, 17:55
Amol Akhade: Should CDK4/6 inhibitors be standard in early HR+/HER2– breast cancer?
Blog
Apr 16, 2025, 17:46
Dégi László Csaba called for action on QoL in cancer care at EUonQol General Assembly - European Cancer Organisation